Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial
- DOI
- 10.1016/j.ejca.2024.114197
- Published
- 2024-11
- Container
- European Journal of Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2024.114197,
title = {Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial},
author = {Soumyajit Roy and Fred Saad and Yilun Sun and Shawn Malone and Daniel E. Spratt and Amar U. Kishan and Christopher J.D. Wallis and Angela Y. Jia and Osama Mohamad and Umang Swami and Michael Ong and Neeraj Agarwal and Simon Chowdhury and Scott C. Morgan},
year = {2024},
journal = {European Journal of Cancer},
doi = {10.1016/j.ejca.2024.114197},
url = {https://doi.org/10.1016/j.ejca.2024.114197}
}RIS
TY - JOUR TI - Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial AU - Soumyajit Roy AU - Fred Saad AU - Yilun Sun AU - Shawn Malone AU - Daniel E. Spratt AU - Amar U. Kishan AU - Christopher J.D. Wallis AU - Angela Y. Jia AU - Osama Mohamad AU - Umang Swami AU - Michael Ong AU - Neeraj Agarwal AU - Simon Chowdhury AU - Scott C. Morgan PY - 2024 JO - European Journal of Cancer DO - 10.1016/j.ejca.2024.114197 UR - https://doi.org/10.1016/j.ejca.2024.114197 ER -
APA
Roy, S., Saad, F., Sun, Y., Malone, S., Spratt, D. E., Kishan, A. U., Wallis, C. J., Jia, A. Y., Mohamad, O., Swami, U., Ong, M., Agarwal, N., Chowdhury, S., & Morgan, S. C. (2024). Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114197
Source records
- crossref · retrieved 2026-09-27T02:39:04.244Z